净销售额及利润 - 公司在2024财年第三季度实现净销售额增长1.9%，达到3.43亿美元，有机销售增长4.5%[34] - 公司在2024财年第三季度实现净利润1489.2万美元，同比增长14.8%[36] 毛利润及成本 - 毛利润在2024财年第三季度增长4.3%，达到1.77亿美元，毛利率提高至51.6%[34] - 研发支出在2024财年第三季度增长12.5%，达到1770万美元，占销售额的5.1%[34] - 销售、一般和管理支出在2024财年第三季度增长5.3%，达到9580万美元，占销售额的27.9%[34] 地区销售情况 - 美洲和亚洲地区有机销售增长率为4.5%，货币影响为-0.1%，总体销售增长率为0.9%[38] - 欧洲和澳大利亚地区有机销售增长率为4.4%，货币影响为-0.6%，总体销售增长率为3.8%[39] - 公司整体有机销售增长率为4.5%，货币影响为-0.3%，总体销售增长率为1.9%[38] 财务状况 - 公司现金及现金等价物在2024年4月30日为1.605亿美元，较2023年7月31日增加了890万美元[43] - 公司信贷协议要求维持债务与过去12个月EBITDA的比率不超过3.5比1，利息支出与过去12个月EBITDA的比率不低于3.0比1，截至2024年4月30日，公司符合这些财务约定[48] 未来展望与风险 - 公司的未来展望涉及未来财务状况、业务策略、销售目标、成本、收入、资本支出、债务水平和现金流等方面[49] - 公司未来业绩可能与前瞻性声明中所述有实质性差异[51] - 公司未发生市场风险方面的重大变化[52]

EXHIBIT 99.1 For More Information: Investor contact: Ann Thornton 414-438-6887 Media contact: Kate Venne 414-358-5176 Brady Corporation Reports Record EPS in its Fiscal 2024 Third Quarter and Raises its Fiscal 2024 EPS Guidance • Sales for the quarter increased 1.9 percent compared to the same quarter of the prior year. Organic sales increased 4.5 percent, foreign currency decreased sales by 0.3 percent and divestitures decreased sales by 2.3 percent. • Diluted EPS increased 9.4 percent to a record high of ...

文章核心观点 - 公司本季度实现创纪录的每股收益和强劲的有机销售增长 [2][13] - 公司持续投资研发为客户创造价值并提高有机销售 [13] - 公司推出多款新产品以区别于竞争对手并补充现有产品线 [13] - 公司保持创新和一贯的优先事项将推动未来增长 [13] - 公司利用强大的资产负债表和现金流回馈股东 [13][14] 财务数据总结 季度财务数据 - 销售额同比增长1.9%,其中有机销售增长4.5%,汇率下降0.3%,剥离业务下降2.3% [6] - 税前利润同比增长2.2%,剔除特殊项目后增长8.2% [7] - 净利润同比增长5.9%,每股收益同比增长9.4%,剔除特殊项目后每股收益增长14.7% [8] 9个月财务数据 - 销售额同比增长1.2%,其中有机销售增长3.0%,汇率上升0.6%,剥离业务下降2.4% [9] - 税前利润同比增长11.0%,剔除特殊项目后增长11.5% [10] - 净利润同比增长13.0%,每股收益同比增长16.3%,剔除特殊项目后每股收益增长16.5% [11][12] 展望 - 公司上调了2024财年的每股收益指引,GAAP基础从3.80-3.95美元提高至3.93-4.00美元,剔除特殊项目后从3.95-4.10美元提高至4.08-4.15美元 [14] - 公司预计2024财年的税率约为21%,折旧摊销费用3000-3200万美元,资本支出约7500万美元 [15] - 公司预计收购Gravotech Holding公司对2024财年每股收益影响不重大 [15]

Sales for the quarter increased 1.9 percent compared to the same quarter of the prior year. Organic sales increased 4.5 percent, foreign currency decreased sales by 0.3 percent and divestitures decreased sales by 2.3 percent. Diluted EPS increased 9.4 percent to a record high of $1.05 in the third quarter of fiscal 2024 compared to $0.96 in the same quarter of the prior year. Diluted EPS Excluding Certain Items* increased 14.7 percent to a record high of $1.09 in the third quarter of fiscal 2024 compared to ...

MILWAUKEE, May 21, 2024 (GLOBE NEWSWIRE) -- On May 20, 2024, Brady Corporation's (NYSE:BRC) Board of Directors declared a dividend to shareholders of the company's Class A Common Stock of $0.235 per share, payable on July 31, 2024, to shareholders of record at the close of business on July 10, 2024. Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady's products help customers increase safety, security, productivit ...

MILWAUKEE, May 21, 2024 (GLOBE NEWSWIRE) -- On May 20, 2024, Brady Corporation's (NYSE:BRC) Board of Directors declared a dividend to shareholders of the company's Class A Common Stock of $0.235 per share, payable on July 31, 2024, to shareholders of record at the close of business on July 10, 2024. Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady's products help customers increase safety, security, productivit ...

Tom Brady has promised to be "a better parent" after a Netflix comedy special poked fun at his divorce. The seven-time Super Bowl champion appeared on The Roast Of Tom Brady, where comedians like Kevin Hart tore into his split from Gisele Bundchen in 2022 after 13 years. While the 46-year-old said he "loved when the jokes were about me," Mr Brady told The Pivot Podcast that he "didn't like the way it affected my kids". "It's the hardest part about, like the bittersweet aspect of when you do something that y ...

MILWAUKEE, March 15, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE:BRC) ("Brady") announced today that it has entered into exclusive negotiations to acquire Gravotech Holding ("Gravotech") for approximately EUR 123 million (approximately USD 133 million). Brady expects to fund the transaction with cash on hand as well as with borrowings on its existing credit agreement, and expects to close the transaction by the end of its fiscal year ending July 31, 2024, subject to prior completion of the information- ...

财务数据和关键指标变化 - 公司本季度实现有机销售增长1.6%,毛利率提升至50.2% [14][19][20] - 非GAAP每股收益增长14.8%,达到0.93美元 [14][15][24] - 营业利润增长15.1%,达到55.8百万美元 [23] - 经营活动现金流增加至36.1百万美元 [25] 各条业务线数据和关键指标变化 - 美洲和亚洲地区有机销售增长1.2%,利润增长9.3% [34][38] - 欧洲和澳大利亚地区有机销售增长2.5%,利润增长11.9% [39][40] - 医疗识别产品线销售下降,其他主要产品线如识别和安全解决方案销售良好 [35][36] - 亚洲业务尤其是中国和印度表现出色,印度销售增长超过21% [37] 各个市场数据和关键指标变化 - 欧洲经济增长放缓,但公司仍能实现高于GDP的有机增长 [39] - 美国工业自动化和项目延迟导致一定销售压力 [34] 公司战略和发展方向及行业竞争 - 公司持续投入研发,新产品管线丰富,未来几个季度将陆续推出多款创新产品 [11][12] - 公司通过区域重组提升运营效率,鼓励团队创新思维,提升客户服务能力 [9][10] - 公司关注识别产品、人员和物品等核心业务,积极评估并剥离不符合战略的业务 [47][48] - 公司保持谨慎的并购策略,关注与现有业务有明确协同的收购标的 [53][54] 管理层对经营环境和未来前景的评论 - 宏观经济环境放缓,但公司业务表现仍优于同行 [44][45][87][88][89] - 公司有信心实现全年业绩指引,并将持续投资于研发和销售资源 [30][31][82][83][84] - 管理层对公司长期发展前景保持乐观,认为新技术如生成式AI将为公司带来新的机遇 [105][106] 问答环节重要的提问和回答 问题1 **Steve Ferazani 提问** 询问公司如何在销售增长放缓的情况下提升利润指引 [44][45] **Russell Shaller 回答** 公司产品组合和地区结构调整,毛利率较高的业务表现良好,同时持续优化运营效率 [45][46][51] 问题2 **Keith Housum 提问** 询问医疗识别产品线的表现情况 [59][60][61] **Russell Shaller 回答** 医疗识别产品线受到一些周期性和结构性因素影响,但公司正在调整产品组合和销售策略以应对 [60][61][62][63] 问题3 **不明身份的分析师提问** 询问公司对下半年业务增长的信心来源 [86][87][88][89] **Russell Shaller 回答** 公司密切关注客户需求,尽管宏观环境存在一些不确定性,但公司业务表现仍优于同行,对下半年保持信心 [88][89][90][91]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 1-14959 BRADY CORPORATION (Exact name of registrant as specified in its charter) Wisconsin 39-0178960 (State or other jurisdiction of incorpora ...